Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer
Clinical trial NCT06578299 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06578299
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2026-03-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.